iRadimed Corporation (IRMD) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.44	$0.46	+4.5%	—	$20.5M	—
Q4 25	$0.48	$0.54	+12.5%	—	$22.7M	—
Q3 25	$0.46	$0.47	+2.2%	—	$21.2M	—
Q2 25	$0.44	$0.49	+11.4%	—	$20.4M	—
Q1 25	$0.41	$0.42	+2.4%	—	$19.5M	—
Q4 24	$0.41	$0.4	-2.4%	—	$19.4M	—
Q3 24	$0.39	$0.43	+10.3%	—	$18.3M	—
Q2 24	$0.37	$0.42	+13.5%	—	$17.9M	—
Q1 24	$0.34	$0.36	+5.9%	—	$17.6M	—
Q4 23	$0.38	$0.39	+2.6%	—	$17.5M	—
Q3 23	$0.37	$0.43	+16.2%	—	$16.5M	—
Q2 23	$0.31	$0.36	+16.1%	—	$16.1M	—
Q1 23	$0.27	$0.3	+11.1%	—	$15.5M	—
Q4 22	$0.31	$0.32	+3.2%	—	$14.9M	—
Q3 22	$0.24	$0.29	+20.8%	—	$13.4M	—
Q2 22	$0.24	$0.26	+8.3%	—	$12.7M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$1.77	—	—	$83.8M	—
FY24	—	$1.52	—	—	$73.2M	—
FY23	—	$1.36	—	—	$65.6M	—
FY22	—	$1.02	—	—	$53.3M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$32.5M	$23.1M	$30.4M	$38.5M	$31.7M	$41.8M	$53.3M	$65.6M	$73.2M	$83.8M
YoY change	+2.86%	-29%	+31.9%	+26.5%	-17.7%	+31.8%	+27.5%	+23%	+11.7%	+14.4%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	32.5M	23.1M	30.4M	38.5M	31.7M	41.8M	53.3M	65.6M	73.2M	83.8M
Cost of revenue	6.2M	5.6M	7.2M	8.8M	8.1M	9.8M	12M	15.4M	16.9M	19.5M
Gross profit	26.3M	17.5M	23.2M	29.7M	23.6M	32M	41.3M	50.2M	56.3M	64.3M
Gross margin	81.1%	75.9%	76.3%	77.1%	74.3%	76.6%	77.4%	76.5%	76.9%	76.7%
Research & development	1.3M	1.7M	1.5M	1.4M	1.9M	1.9M	2.3M	2.9M	2.8M	3M
Selling, general & administrative	14.1M	14.5M	15.7M	19.6M	22.4M	20.3M	23.4M	27.3M	31.6M	35.2M
Operating expenses	15.4M	16.2M	17.2M	21.1M	24.3M	22.2M	25.7M	30.1M	34.4M	38.2M
Operating income	10.9M	1.3M	6M	8.6M	-756.1K	9.8M	15.6M	20M	22M	26.1M
Operating margin	33.6%	5.57%	19.7%	22.5%	-2.38%	23.5%	29.3%	30.6%	30%	31.2%
Non-operating income, net	-93.7K	-11.2K	-44.6K	7.1K	7K	-16.2K	-28.7K	-161.3K	117.6K	205K
Pretax income	11M	1.4M	6.2M	9M	-616.9K	9.8M	16.2M	21.7M	24.3M	28.4M
Income tax	3.7M	896.6K	-106.1K	-587.6K	-2M	510.8K	3.4M	4.5M	5M	5.9M
Net income	7.2M	499.8K	6.3M	9.6M	1.4M	9.3M	12.8M	17.2M	19.2M	22.5M
Net margin	22.2%	2.17%	20.7%	25%	4.32%	22.3%	24.1%	26.2%	26.3%	26.8%
EBITDA	12M	2.6M	7.2M	9.9M	575.7K	11.2M	16.3M	21M	22.8M	27.1M
EPS	0.67	0.05	0.59	0.85	0.11	0.76	1.02	1.36	1.52	1.77
Diluted EPS	0.6	0.04	0.52	0.78	0.11	0.74	1.02	1.35	1.5	1.75

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	16.5M	17.5M	17.6M	17.9M	18.3M	19.4M	19.5M	20.4M	21.2M	22.7M	22M	20.5M
Cost of revenue	3.7M	4M	4.2M	3.9M	4.1M	4.6M	4.7M	4.5M	4.7M	5.7M	5.2M	5.3M
Gross profit	12.8M	13.4M	13.4M	14M	14.2M	14.8M	14.8M	16M	16.5M	17M	16.8M	15.2M
Gross margin	77.8%	76.9%	76.1%	78.1%	77.4%	76.1%	76.1%	78.2%	77.8%	75.1%	76.5%	74.1%
Research & development	452.6K	650.4K	821K	801.1K	639.5K	570K	624.2K	877.4K	674.4K	799K	956K	657K
Selling, general & administrative	6.5M	7.6M	7.8M	7.6M	7.8M	8.4M	8.8M	8.3M	9M	9.1M	8.6M	8.1M
Operating expenses	6.9M	8.3M	8.6M	8.4M	8.4M	9M	9.4M	9.2M	9.7M	9.9M	9.6M	8.8M
Operating income	5.9M	5.2M	4.7M	5.6M	5.8M	5.8M	5.4M	6.8M	6.8M	7.1M	7.2M	6.4M
Operating margin	35.8%	29.6%	27%	31.4%	31.6%	29.9%	27.8%	33.3%	32.2%	31.3%	32.9%	31.2%
Non-operating income, net	503.2K	-1.3M	495.2K	642.2K	629.2K	-1.6M	514K	539.2K	464K	-1.3M	532K	497K
Pretax income	6.4M	5.7M	5.2M	6.3M	6.4M	6.3M	5.9M	7.3M	7.3M	7.8M	7.8M	6.9M
Income tax	1.3M	1.1M	1.1M	1.4M	1.4M	1.2M	1.3M	1.6M	1.7M	1.3M	2M	1.7M
Net income	5.1M	4.5M	4.1M	4.9M	5M	5.1M	4.7M	5.8M	5.6M	6.4M	5.8M	5.2M
Net margin	30.7%	26%	23.5%	27.3%	27.6%	26.5%	24%	28.3%	26.3%	28.4%	26.5%	25.5%
EBITDA	6.1M	5.4M	5M	5.8M	6M	6M	5.6M	7M	7.2M	7.5M	7.7M	6.8M
EPS	0.4	0.36	0.33	0.39	0.4	0.41	0.37	0.45	0.44	0.51	0.46	0.41
Diluted EPS	0.4	0.36	0.32	0.38	0.4	0.4	0.37	0.45	0.43	0.5	0.45	0.41

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	120.1M	161.2M	263.2M	263.8M	276.4M	570.5M	355.4M	598.3M	696.9M	1.2B	1.1B
Enterprise value	94.4M	134.8M	228.8M	220.5M	227.2M	510.5M	299.6M	550.5M	644.8M	1.2B	1B
Shares outstanding	10.8M	10.6M	10.8M	11.3M	12.1M	12.3M	12.6M	12.6M	12.7M	12.7M	12.7M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	16.6	322.5	41.7	27.4	201.9	61.2	27.7	34.8	36.2	55.1	47.9
P/S	3.7	6.98	8.65	6.85	8.72	13.6	6.67	9.13	9.51	14.8	12.7
P/B	3.77	4.89	6.27	4.75	4.5	7.9	4.82	8.38	8.03	13.1	10.8
EV/EBITDA	7.89	51.8	32	22.3	394.6	45.4	18.4	26.3	28.2	43.8	35.6
EV/Sales	2.91	5.84	7.52	5.72	7.16	12.2	5.62	8.4	8.8	14.2	12
Earnings yield	6.01%	0.31%	2.4%	3.65%	0.5%	1.63%	3.61%	2.87%	2.76%	1.82%	2.09%
FCF yield	6.56%	1.61%	2.7%	3.7%	1.87%	1.84%	2.3%	0.91%	2.41%	1.34%	1.46%
PEG	—	—	—	—	—	—	—	—	—	—	-5.39

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	81.1%	75.9%	76.3%	77.1%	74.3%	76.6%	77.4%	76.5%	76.9%	76.7%	74.1%
Operating margin	33.6%	5.57%	19.7%	22.5%	-2.38%	23.5%	29.3%	30.6%	30%	31.2%	31.2%
Net margin	22.2%	2.17%	20.7%	25%	4.32%	22.3%	24.1%	26.2%	26.3%	26.8%	26.7%
ROE	22.6%	1.52%	15%	17.3%	2.23%	12.9%	17.4%	24.1%	22.2%	23.8%	23.5%
ROA	19.4%	1.28%	13%	14.4%	1.93%	11.3%	15%	18.7%	19.6%	20.7%	15.6%
ROIC	115.8%	6.98%	79.3%	70.7%	-6.24%	76.6%	69.2%	66.9%	50.1%	47.7%	50.1%
Return on tangible assets	20.4%	1.34%	13.5%	14.8%	1.98%	11.6%	15.8%	19.7%	20.9%	22%	21.3%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	9.25	8.61	9.5	10.1	13	11.2	9.06	4.65	8.84	7.98	9.46
Quick ratio	8.18	7.58	8.63	9.44	12.2	10.5	8.43	3.87	7.62	6.84	8.13
Debt / equity	—	—	0	0.05	0.04	0.03	0.03	0.03	0	0	0
Debt / assets	—	—	0	0.04	0.04	0.03	0.03	0.02	0	0	0
Net debt / EBITDA	—	—	-4.81	-4.38	-85.6	-5.34	-3.41	-2.28	-2.28	-1.89	-2.02
Effective tax rate	34.1%	64.2%	0%	0%	0%	5.19%	20.7%	20.9%	20.8%	20.7%	22.5%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	3	2.17	2.83	3.41	2.62	3.39	4.24	5.2	5.78	6.59	6.77
EPS (basic)	0.67	0.05	0.59	0.85	0.11	0.76	1.02	1.36	1.52	1.77	1.77
EPS (diluted)	0.6	0.04	0.52	0.78	0.11	0.74	1.02	1.35	1.5	1.75	1.79
Book value per share	2.95	3.1	3.9	4.92	5.06	5.85	5.86	5.67	6.85	7.44	7.96
FCF per share	0.73	0.24	0.66	0.86	0.43	0.85	0.65	0.43	1.33	1.3	1.91
Cash per share	2.37	2.48	3.2	4.1	4.29	5.06	4.61	3.95	4.12	4.02	4.62
Capex per share	0.07	0.07	0.02	0.03	0.04	0.04	0.07	0.59	0.63	0.05	0.04

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	2.4%	3.36%	0.75%	0.96%	1.4%	1.15%	1.54%	11.3%	10.9%	0.78%	0.66%
Capex / operating cash flow	7.99%	19.4%	2.67%	3.75%	4.9%	4.06%	12.7%	55.2%	31.2%	2.63%	2.11%
Payout ratio	—	—	—	—	—	0%	97.9%	76.9%	71.1%	66.9%	41.3%
Dividend yield	—	—	—	—	—	0%	3.53%	2.21%	1.96%	1.22%	0.92%

Yield

0.92%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.20

ex-dividend Aug 14, 2026

Payout ratio

41%

of earnings

Dividend growth

1 year

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 14, 2026	$0.20
May 15, 2026	$0.20
Feb 23, 2026	$0.20
Dec 17, 2025	$0.50
Nov 14, 2025	$0.17
Aug 18, 2025	$0.17
May 20, 2025	$0.17
Feb 24, 2025	$0.17

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$16.5M	$17.5M	$17.6M	$17.9M	$18.3M	$19.4M	$19.5M	$20.4M	$21.2M	$22.7M	$22M	$20.5M
YoY change	+23.1%	+17.4%	+13.7%	+11.1%	+11%	+11.1%	+10.9%	+13.8%	+15.7%	+17%	+12.7%	+0.28%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	25.7M	26.3M	34.4M	46.3M	52M	62.5M	58M	49.8M	52.2M	51.2M
Receivables	3.8M	3.8M	4.2M	7.3M	4.6M	5.1M	13.3M	12.2M	10.6M	13.7M
Inventory	3.9M	4.2M	4.1M	3.6M	3.9M	4.3M	5.4M	12.8M	10.4M	11.6M
Total current assets	33.9M	35.1M	44.5M	59M	63.7M	76.2M	77.5M	76M	75.2M	81.2M
Property, plant & equipment	1.5M	1.9M	1.9M	5M	4.8M	4.6M	4.6M	11.3M	17M	12.3M
Goodwill & intangibles	1.8M	1.8M	1.7M	1.7M	1.9M	2.2M	4.1M	5M	6.2M	6.8M
Total assets	37.2M	39M	48.4M	66.7M	71.1M	82.9M	85.5M	92.2M	98.3M	108.8M
Accounts payable	1.1M	656.7K	772.5K	993.7K	657.1K	782.9K	1.8M	1.9M	1.9M	1.8M
Short-term debt	—	—	—	240.8K	255.7K	276.6K	293.5K	428K	153.3K	—
Total current liabilities	3.7M	4.1M	4.7M	5.9M	4.9M	6.8M	8.6M	16.3M	8.5M	10.2M
Long-term debt	—	—	0	2.7M	2.5M	2.2M	1.9M	1.6M	1.4K	0
Total liabilities	5.3M	6.1M	6.5M	11.2M	9.7M	10.7M	11.8M	20.7M	11.5M	14.2M
Shareholders' equity	31.9M	32.9M	41.9M	55.5M	61.4M	72.2M	73.7M	71.4M	86.8M	94.6M
Total debt	—	—	0	3M	2.7M	2.5M	2.2M	2M	154.7K	0
Net debt	—	—	-28M	-40.5M	-47.4M	-59.5M	-55.8M	-47.7M	-52.1M	-51.2M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	46.7M	49.8M	45.1M	48.5M	51.7M	52.2M	50.3M	53M	56.5M	51.2M	56.4M	59.1M
Receivables	12.8M	12.2M	13M	12M	10.4M	10.6M	12.7M	10.9M	13.9M	13.7M	13.4M	13.2M
Inventory	11.7M	12.8M	12.7M	12.1M	11.3M	10.4M	10.6M	11.2M	11.7M	11.6M	11.9M	12.3M
Total current assets	71.9M	76M	71.9M	73.6M	74.3M	75.2M	75.1M	77.4M	84.9M	81.2M	86.4M	86.7M
Property, plant & equipment	11M	11.3M	11.4M	10.8M	14.4M	17M	20.4M	22.9M	12.3M	12.3M	12.7M	12.7M
Goodwill & intangibles	4.9M	5M	5.3M	5.5M	5.8M	6.2M	6.5M	6.7M	6.7M	6.8M	6.6M	6.9M
Total assets	87.4M	92.2M	88M	89.9M	94.2M	98.3M	101.7M	106.4M	114.7M	108.8M	114.4M	115M
Accounts payable	2.8M	1.9M	1.3M	1.1M	1.4M	1.9M	2.6M	1.9M	2.3M	1.8M	2.2M	1.8M
Short-term debt	421.4K	428K	418.8K	367.6K	261.2K	153.3K	59.2K	—	—	—	—	—
Total current liabilities	7.9M	16.3M	7.6M	7.5M	8.1M	8.5M	8.5M	8.8M	12.8M	10.2M	12.1M	9.2M
Long-term debt	1.7M	1.6M	1.5M	4.2K	2.8K	1.4K	0	0	0	0	—	—
Total liabilities	12.8M	20.7M	11.9M	10.3M	10.8M	11.5M	11.7M	12.1M	16.4M	14.2M	15.9M	13.2M
Shareholders' equity	74.6M	71.4M	76.1M	79.7M	83.4M	86.8M	90.1M	94.3M	98.4M	94.6M	98.5M	101.7M
Total debt	2.1M	2M	1.9M	371.8K	264.1K	154.7K	59.2K	0	0	0	—	—
Net debt	-44.6M	-47.7M	-43.2M	-48.2M	-51.5M	-52.1M	-50.3M	-53M	-56.5M	-51.2M	—	—

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	7.2M	499.8K	6.3M	9.6M	1.4M	9.3M	12.8M	17.2M	19.2M	22.5M
Depreciation & amortization	955.8K	1.3M	1.1M	1.2M	1.3M	1.4M	670.7K	765.2K	817.7K	1.2M
Stock-based compensation	1.8M	2.5M	1.8M	1.9M	4M	1.5M	1.4M	2.2M	2.5M	2.9M
Change in working capital	327.2K	-120.8K	-461.2K	-2.3M	2M	-845K	-8.5M	-5.5M	3.8M	-3M
Operating cash flow	9.8M	4M	8.6M	9.8M	9M	11.9M	6.5M	13.5M	25.7M	24.9M
Capital expenditure	-780.8K	-775.6K	-228.3K	-368.3K	-443K	-482.3K	-823K	-7.4M	-8M	-656K
Investing cash flow	-1.2M	-974.3K	1.6M	3.3M	440.7K	907.7K	-323K	-7.4M	-8M	-656K
Dividends paid	—	—	—	—	—	0	-12.6M	-13.2M	-13.7M	-15M
Share repurchases	-10M	-1.8M	0	0	—	—	—	—	—	—
Financing cash flow	-9.4M	-2M	-309.6K	-473.1K	-1.2M	-598.8K	-12.9M	-13.8M	-14.4M	-17.6M
Net change in cash	-795.7K	1M	9.8M	12.7M	8.3M	12.2M	-6.7M	-7.8M	3.3M	6.7M
Free cash flow	7.9M	2.6M	7.1M	9.7M	5.2M	10.5M	8.2M	5.5M	16.8M	16.5M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	5.1M	4.5M	4.1M	4.9M	5M	5.1M	4.7M	5.8M	5.6M	6.4M	5.8M	5.2M
Depreciation & amortization	189.9K	205.4K	226.1K	199.1K	197.6K	194.9K	194.1K	207.6K	383.3K	380.7K	455K	410K
Stock-based compensation	533.7K	551.1K	628.6K	609.1K	630K	656.8K	826.1K	730.7K	665.8K	696.2K	684K	807K
Change in working capital	-4.1M	-1.3M	-1.6M	1.6M	2.6M	1.1M	-1.2M	1.2M	-2.9M	-167.1K	358K	-206K
Operating cash flow	1.6M	3.9M	4.3M	5.7M	8.6M	7M	4.7M	7.7M	7M	5.9M	8.3M	5.9M
Capital expenditure	-308.1K	-531.9K	-270.6K	-1.1M	-3.8M	-2.8M	-3.7M	-187.8K	-125.8K	-122.2K	-66K	-258K
Investing cash flow	-308.1K	-531.9K	-270.6K	-1.1M	-3.8M	-2.8M	-3.7M	-187.8K	-125.8K	-122.2K	-66K	-258K
Dividends paid	0	0	-8M	-1.9M	-1.9M	-1.9M	-2.2M	-2.2M	-2.2M	-8.6M	-2.6M	-2.6M
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-31.4K	-432K	-8M	-2M	-1.9M	-2.4M	-2.3M	-2.3M	-2.2M	-10.9M	-2.6M	-2.8M
Net change in cash	1.3M	3M	-4M	2.6M	2.9M	1.8M	-1.3M	5.3M	4.7M	-5.1M	5.6M	2.9M
Free cash flow	953.7K	3.3M	3.4M	5.4M	5.1M	2.9M	374.8K	4.9M	5.7M	5.5M	7.8M	5.5M

iRadimed Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement